CHW Patient Portal Access      -      Our New Medical Spa is Now Open!   Modern Medical Spa  -  509-392-5007
Skip to main content

Weight Loss and GLP-1 Agonists

GLP-1 Agonists - Weight Loss

Glucagon-like peptide 1 (GLP-1) agonists are a class of drugs used in the management of type 2 diabetes. These drugs also aid in weight loss.  Some drugs that are GLP-1 agonists are Mounjaro and Ozempic.   They work by mimicking the effects of the hormone GLP-1, which is naturally produced by the body to regulate blood sugar levels. In this article, we will explore the mechanism of action, benefits, and potential side effects of GLP-1 agonists.


What is a GLP-1 agonist?

A GLP-1 agonist is a type of medication that works by mimicking the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone that is released after eating, and it helps to regulate appetite, blood sugar levels, and weight.

How do GLP-1 agonists work?

GLP-1 agonists bind to the GLP-1 receptors in the body. These receptors are located on the cells in the pancreas, liver, and brain. When GLP-1 agonists bind to these receptors, they signal the cells to release insulin, which helps to lower blood sugar levels. GLP-1 agonists also signal the cells in the pancreas to produce more glucagon, which helps to raise blood sugar levels if they get too low. In addition, GLP-1 agonists slow down the emptying of the stomach, which helps to make you feel full after eating. This can lead to weight loss.

What are the benefits of GLP-1 agonists?

GLP-1 agonists have been shown to be effective in treating type 2 diabetes. They can help to lower blood sugar levels, reduce the risk of heart disease and stroke, and help with weight loss. GLP-1 agonists are also being studied for the treatment of other conditions, such as obesity, polycystic ovary syndrome (PCOS), and gastroparesis.


GLP-1 is released into the bloodstream in response to food consumption, causing an increase in insulin secretion and a decrease in glucagon release, leading to a reduction in blood sugar levels. In individuals with type 2 diabetes, this natural regulation of glucose is impaired, resulting in elevated blood sugar levels. GLP-1 agonists work by imitating the effects of GLP-1, thereby increasing insulin secretion and decreasing glucagon release, leading to improved glucose control.

One of the main benefits of GLP-1 agonists is their ability to reduce blood sugar levels. In clinical trials, they have been shown to significantly lower HbA1c, a measure of long-term blood sugar control, compared to a placebo. Additionally, they have been shown to have a beneficial effect on weight loss in individuals with obesity, which is often a comorbidity in type 2 diabetes.

GLP-1 agonists also have a low risk of causing hypoglycemia, or low blood sugar, which is a common side effect of many diabetes medications. This is because GLP-1 agonists stimulate insulin secretion only in response to elevated blood sugar levels, and not when blood sugar levels are normal or low.

Another advantage of GLP-1 agonists is their potential to improve cardiovascular outcomes. In clinical trials, GLP-1 agonists have been shown to reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, compared to a placebo. This benefit is thought to be due to the drug's ability to improve glucose control, lower blood pressure, and reduce body weight.

However, as with all drugs, GLP-1 agonists are associated with potential side effects. The most common side effects include nausea, vomiting, and diarrhea, which are typically mild and resolve on their own after a few days. More serious side effects, such as pancreatitis and kidney problems, have been reported in some cases, but these are rare.

In conclusion, GLP-1 agonists are a valuable tool in the management of type 2 diabetes, offering benefits such as improved glucose control, weight loss, and reduced risk of cardiovascular events. While there are potential side effects associated with the use of these drugs, they are generally mild and manageable. Individuals with type 2 diabetes should discuss the potential benefits and risks of GLP-1 agonists with their healthcare provider to determine if they are a good option for them.

Complete Healthcare for Women - Obstetrics and Gynecology


Richard Lorenzo, D.O.

Kortney Jones ARNP

Dr. Lorenzo Richard Lorenzo, DO Dr. Lorenzo is also a Fellow of the American Congress of Obstetricians and Gynecologists and a Fellow of the American College of Osteopathic Obstetricians and Gynecologists. He provides gynecological and obstetric services, including prenatal care, pregnancy care, infertility, and gynecology. Dr. Lorenzo is proficient in advanced surgical techniques, including minimally-invasive procedures, as well as surgery for abnormal uterine bleeding, endometriosis, and hysterectomy. He has specialized training in high-risk obstetrics and minimally invasive surgical techniques, including minimally invasive hysterectomy.

You Might Also Enjoy...


Prevention is Key: Managing Vaginitis in Women's Health

Vaginitis is a common medical condition that can cause significant discomfort and distress. Seeking medical attention is crucial if you suspect you have vaginitis, as it can usually be treated with medication and lifestyle changes.